Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.

Antimicrob Agents Chemother

Clinical Pharmacokinetic Laboratory, Haut-Lévêque Hospital, University of Bordeaux II, Bordeaux, Lyon, France.

Published: October 1999

The objective of this study was to analyze the pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration. Six patients received 15 mg of isepamicin per kg of body weight. The mean isepamicin concentration peak in serum was 62.88 +/- 18.20 mg/liter 0.5 h after the infusion. The elimination half-life was 7. 91 +/- 0.83 h. The mean total body clearance was 1.75 +/- 0.28 liters/h, and dialysate outlet (DO) clearance was 2.76 +/- 0.59 liters/h. The mean volume of distribution was 19.83 +/- 2.95 liters. The elimination half-life, DO clearance, and volume of distribution were almost constant. In this group of patients, the initial dosage of 15 mg/kg appeared to be adequate, but the dosage interval should be determined by monitoring residual isepamicin concentrations in plasma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC89492PMC
http://dx.doi.org/10.1128/AAC.43.10.2409DOI Listing

Publication Analysis

Top Keywords

pharmacokinetics isepamicin
8
isepamicin continuous
8
continuous venovenous
8
venovenous hemodiafiltration
8
elimination half-life
8
volume distribution
8
+/-
5
hemodiafiltration objective
4
objective study
4
study analyze
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!